The GS MedTech
Podcast

From a landmark stroke patient who recovered beyond all clinical expectations, to closed-loop brain-computer interfaces that listen and respond to the brain in real time - CorTec is challenging decades of assumptions about what's possible in neurological care.
Frank Desiere, CEO of CorTec, joined us

Tresquare Technologies is pioneering a new approach to TAVI-in-TAVI procedures for degenerated aortic bioprostheses. Its platform is designed to mechanically resect and remove calcified leaflets before a transcatheter valve is implanted, a potential game-changer in improving haemodynamic outcomes an

Why has the synthetic meniscus been called MedTech's "holy grail"? ATRO Medical's new CEO Maarten van der Zanden explains what makes the Artimis artificial meniscus prosthesis different. 
Backed by a fresh €3M round, ATRO is now preparing for pivotal studies in the US and Europe. Learn more abou

Phil Kemp, President & Chief Operating Office at X-Bolt Orthopedics sat down with Dame to share how he's building a next-generation fixation platform after years at Stryker. From navigating the $50K cost of hip fracture failure to scaling trust before revenue, Phil reveals what it takes to solve

We sat down with Declan Soden, CEO at Mirai Medical, who shared how pulsed electric field technology is transforming GI cancer treatment with zero adverse events in 100 patients.
He shares details about efficiently raising €30M, building the right team, navigating oncology adoption barriers, and scal

In this episode of the GS MedTech Podcast, we sit down with Niklas Green, Head of Invesdor Nordics, to explore one of the most misunderstood funding routes in MedTech - crowdfunding.
If you are trying to navigate your next funding round, this episode will answer the questions you should be asking. Fr

Most neurology departments need a simple, low-cost brain PET solution that does not require major operational complexity.
Jannis Fischer and his team at Positrigo have developed NeuroLF: a dedicated brain PET, designed to be ultra-compact and usable closer to point-of-care, which makes it far more re

John Erbey from Roivios highlights an often overlooked organ: the kidneys. During cardiac surgery, if they fail to sustain a stable internal environment, this can lead to a higher risk of other organs failing.
"If you keep the kidney alive, the patient can thrive," John shared to Dame Medarski during

Most European founders would flinch at the idea of manufacturing their device in Singapore. Yet Jean-Luc, Group Director at MDS+, reveals that superior cost efficiency, high quality, and compressed timelines are only part of the story behind why looking East can be a smart manufacturing decision.
Whe

Zeev Dvashi and the Plas-Free team recently secured CE Mark for their ClearPlasma device - an innovative technology that removes fibrinolytic factors from blood products, strengthening clot formation and improving bleeding control. 🩸
In this episode, Zeev looks beyond the technical milestones and sh